Conference Reports for NATAP

5th International Workshop on Hepatitis C Resistance and New Compounds 24-25 June 2010, Boston, MA USA Back

HCV NS5A Targeted Antivirals (BMS-790052)       Boston --June 24 & 25, 2010, HCV Drug Resistance New Compounds Workshop   Min Gao   Department of Infectious Disease Bristol--Myers Squibb Research Myers Research   Once-daily NS5A Inhibitor (BMS-790052) Plus Peginterferon-alpha-2a ... Apr 17, 2010 ... Once-daily NS5A Inhibitor (BMS-790052) Plus Peginterferon-alpha-2a And Ribavirin Produces High Rates Of Extended Rapid Virologic Response In ... www.natap.org/2010/EASL/EASL_32.htm   BMS NS5A HCV Inhibitor - chemical genetics discovery process in ... Here we describe the profile of BMS-790052, a small molecule inhibitor of the HCV NS5A protein that exhibits picomolar half-maximum effective concentrations ... www.natap.org/2010/HCV/042210_01.htm